FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Voucher Redeemed on Fabhaltas Approval

Federal Register notice: FDA announces the approval of a product that redeemed a material threat medical countermeasure priority review voucher Novar...

latest-news-card-1
Medical Devices

Alert on Equinoxe Shoulder Implants

FDA alerts patients and healthcare providers about Exactechs Equinoxe Shoulder System joint replacement devices and possible health risks.

latest-news-card-1
Medical Devices

ROi CPS Surgical Kits Recalled

ROi CPS recalls its Regard Operative Lap P&S Surgical Kit due to sterility concerns.

latest-news-card-1
Human Drugs

Hyloris Pharma Orphan Designation for AML

FDA grants Hyloris Pharmaceuticals an orphan drug designation for PTX-252 for treating acute myeloid leukemia.

Human Drugs

Matsui, Buschon Introduce Drug Shortage Bill

Reps. Matsui and Buschon introduce bipartisan legislation they say will help the federal government anticipate and mitigate drug shortages.

latest-news-card-1
Human Drugs

FDA Off-Label Enforcement Increasing: Attorney

Attorney Chia-Feng Lu sees increasing FDA interest in guidance on and enforcement of off-label communications.

latest-news-card-1

Court Cuts Covid Vaccine FOIA Stay to 6 Months

The DC federal court approves a six-month stay in FDAs records production for an FOIA request from Childrens Health Defense for records related to Cov...

latest-news-card-1
Human Drugs

Bill to Stockpile Pediatric Cancer Drugs

Three Democrat U.S. Reps. introduce the Pediatric Cancer Drug Supply Act of 2024, legislation that is intended to ensure there is an adequate supply o...

latest-news-card-1
Human Drugs

45% of CDER Warning Letters Cited GMPs: Report

CDER says 45% of drug Warning Letters issued in fiscal year 2023 cited GMP requirement violations.

latest-news-card-1
Federal Register

Guide on Biologic Viral Safety Evaluations

Federal Register notice: FDA makes available a final guidance entitled Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lin...